WallStreetZenWallStreetZen

NASDAQ: IMVT
Immunovant Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

IMVT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$243.4M
Current Profit Margin
0%

IMVT Return on Equity

Current Company
-61.1%
Current Industry
-63.5%
Current Market
188%
IMVT's Return on Equity (-61.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IMVT announces earnings.

IMVT Return on Assets

Current Company
-55.3%
Current Industry
2.9%
IMVT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IMVT Return on Capital Employed

Current Company
-35.93%
Current Industry
19.5%
IMVT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMVT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IMVT$0.00-$242.72M-$243.45MN/AN/A
MDGL$0.00-$360.39M-$373.63MN/AN/A
INSM$305.21M-$645.53M-$749.57M+98.78%N/A
ALPN$58.88M-$31.41M-$32.18M+142.30%N/A
RARE$434.25M-$582.46M-$606.64M+53.18%N/A
View Top Biotech Stocks

IMVT earnings dates

Next earnings date
May 13, 2024

Immunovant Earnings & Revenue FAQ

What were IMVT's earnings last quarter?

On Invalid Date, Immunovant (NASDAQ: IMVT) reported Q4 2023 earnings per share (EPS) of -$0.36, up 26.53% year over year. Total Immunovant earnings for the quarter were -$51.42 million. In the same quarter last year, Immunovant's earnings per share (EPS) was -$0.49.

If you're new to stock investing, here's how to buy Immunovant stock.

What was IMVT's earnings growth in the past year?

As of Q2 2024, Immunovant's earnings has grown year over year. Immunovant's earnings in the past year totalled -$243.45 million.

What is IMVT's earnings date?

Immunovant's earnings date is Invalid Date. Add IMVT to your watchlist to be reminded of IMVT's next earnings announcement.

What was IMVT's revenue last quarter?

On Invalid Date, Immunovant (NASDAQ: IMVT) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Immunovant's revenue was $0.00.

What was IMVT's revenue growth in the past year?

As of Q2 2024, Immunovant's revenue has grown null year over year. Immunovant's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.